| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Ofc Imm Med | Chief Business Development Off
1 company
Benzeno Sharon is a Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,770 | $55.65 | $376,719.70 | -95.8% | |
| Jan 19, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 417 | $69.00 | $28,773.00 | -100% | |
| Jan 4, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,771 | $57.39 | $388,582.75 | -54.8% | |
| Dec 21, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 417 | $59.14 | $24,661.38 | -100% | |
| Dec 1, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,770 | $48.87 | $330,856.39 | -64.7% | |
| Nov 19, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 416 | $48.86 | $20,325.76 | -100% | |
| Nov 2, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,772 | $45.58 | $308,642.42 | -86.3% | |
| Oct 19, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 417 | $51.25 | $21,371.25 | -100% | |
| Oct 1, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,771 | $48.57 | $328,837.06 | -88.3% | |
| Sep 21, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 417 | $45.51 | $18,977.67 | -100% |